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Abstract
Hemangiosarcoma (HSA) is a malignant neoplasm originating from the vascular endothelium, with high metastatic 
power and commonly described in the spleen, liver, and right atrium. Thus, the objective of the present study is to 
report the occurrence of HSA at the base of the left atrium of a male, elderly, Lhasa Apso dog, treated with cyanosis, 
orthopedic position, cough. In the physical examination, the presence of crackling was observed in pulmonary 
lobes, murmur in focus of mitral and tricuspid grade IV\VI. The recommended emergency therapy was performed 
until the clinical improvement of the animal. After echocardiography, mitral and tricuspid valvular degeneration 
was confirmed, as well as the presence of an irregular, mixed echocardiogram, extra-cardiac, immobile at the base of 
the left atrium, measuring 2.9 x 1.44 cm in diameter. The clinical therapy established stabilized the clinical picture 
for 128 days, with recurrence of pulmonary edema and severe hemorrhagic pleural effusion, with the owners opting 
for euthanasia of the animal and necropsy confirming the definitive diagnosis of extrahepatic SAH at the base of the 
left atrium.
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Resumo
O hemangiossarcoma (HSA) é uma neoplasia maligna originada no endotélio vascular, com alto poder metastático 
e comumente descrito no baço, fígado e átrio direito. Assim, o objetivo deste trabalho é relatar a ocorrência do HSA 
na base do átrio esquerdo de um cão, macho, idoso, da raça Lhasa Apso, atendido apresentando cianose, posição 
ortopneica e tosse. No exame físico foi observado presença de crepitação em lobos pulmonares e sopro em foco 
de mitral e tricúspide grau IV\VI. Foi realizada terapia emergencial preconizada até a melhora clínica do animal, 
e após a ecocardiografia confirmou-se a degeneração valvular mitral e tricúspide, bem como a presença de uma 
imagem irregular, de ecogenicidade mista, extracardíaca e imóvel na base do átrio esquerdo, medindo 2,9 x 1,44 
cm de diâmetro. A terapia clínica instituída estabilizou o quadro clínico por 128 dias, havendo recidiva do edema 
pulmonar e efusão pleural hemorrágica grave, com os proprietários optando pela eutanásia do animal e a necropsia, 
confirmando o diagnóstico definitivo do HSA extracardíaco na base do átrio esquerdo.
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Hemangiosarcoma (HSA) is a malignant neoplasm 
of endothelial cells of aggressive behavior, with great 
capacity of infiltration and metastases in the liver, spleen, 
heart, lung, mesentery, skin, and subcutaneous tissue 
(VERBEKE et al., 2012). In addition, atrioventricular 
junction and left ventricle (PALACIO et al., 2006) have 
been reported in the literature. The intensity of the 
cardiovascular changes determined by this neoplasm 
may vary according to its location, size, presence of 
pericardial effusion, and cardiac tamponade (FERREIRA 
et al., 2011). Clinical findings are generally congestive 
heart failure (CHF), hypovolemic shock caused by 
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neoplastic mass rupture and arrhythmias (WARMAN 
et al., 2006). The definitive diagnosis is made through 
clinical history, radiographic and echocardiographic 
findings, and samples of paracentesis or thoracentesis 
sent for cytological and histopathological examination 
(BROWN et al., 1985). The surgical treatment is based 
on pericardiectomy and tumor resection, providing a 
palliative reduction of the signs, followed or not by a 
coadjuvant chemotherapy (WEISSE et al., 2005). The 
clinical treatment consists of the chemotherapy protocol 
to be performed as adjuvant to the surgical one, with 
good results in the control of metastases and increase 
of the patient’s life expectancy (WEISSE et al., 2005). 
The indicated chemotherapy protocols are VAC I 
and VAC II, which consist of administration of the 
combination of Doxorubicin, Cyclophosphamide, and 
Vincristine (FREIRE, 2009). Since the clinical signs 
observed in dogs with thoracic HSA are similar to those 
described in patients with CHF with mitral and tricuspid 
valve degeneration (DVT), differential diagnosis is 
recommended as a function of respiratory compromise 
and hemodynamic changes (NELSON; COUTO, 2010). 
Therefore, the aim of the present study is to report the 
occurrence of left atrial HSA in a dog with DVTD.
Figure 1 –  Echocardiographic images of a male dog with HSA, obtained through the right and left parasternal 
window, showing circular, extracardiac images, overlapping the left atrium
A 13-year-old Lhasa Apso male dog arrived for 
clinical care with cyanosis, orthopedic position, 
cough, and progressive weight loss five days earlier. 
Physical examination revealed crackling in pulmonary 
lobes, cyanotic mucosa, murmur in focus of mitral 
and tricuspid grade IV\VI (holosystolic), body score 
three, and hepatomegaly. Outpatient treatment 
based on oxygen therapy and furosemide (4 mg/kg) 
was administered through two intravenous boluses 
every two hours, followed by continuous infusion 
(0.1 mg/kg/h) for two hours, until the clinical 
improvement of the animal was obtained. Laboratory 
tests showed normocytic normochromic anemia, renal 
azotemia, hyperphosphataemia, and increased liver 
enzymes. The chest X-ray revealed pulmonary edema 
and cardiomegaly. The electrocardiogram showed 
fifteen premature ventricular complexes (CVP) in 
three minutes and echocardiography confirmed the 
presence of DVTM with mild pulmonary hypertension 
and an irregular, mixed echogenicity image Cardiac, 
immobile at the base of the left atrium, measuring 2.9 
x 1.44 cm in diameter. Thus, the presence of an extra-
cardiac neoplasia and functional class D-DVMT was 
confirmed. With clinical improvement of the animal, 
benazepril hydrochloride, spironolactone, furosemide, 
and sildenafil of continuous use were prescribed together 
with ranitidine and prednisolone for 5 days, both 
orally (VO). In the clinical reassessment in 7 days, the 
clinical improvement of the animal was observed, with 
the progressive withdrawal in 10 days of prednisolone 
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Figure 2 –  Photomicrograph of left atrial he-rosiosarcoma. Note the 
atypical endothelial cells (arrows). HE, 20x objective
and the inclusion of aluminum hydroxide by VO, 
and the remaining medications were maintained. A 
new clinical, radiographic, electrocardiographic, and 
echocardiographic evaluation was performed 30 days 
after the start of therapy, confirming the absence of 
pulmonary edema and ventricular arrhythmias, but 
maintenance of the extracardiac image at the base of 
the left atrium (Figure 1). However, the animal still 
had episodes of sporadic dry cough, and an antitussive 
based on clobutinol hydrochloride and doxylamine 
succinate was then prescribed every 12 hours for 15 
days. Animal was clinically stable for 128 days, but with 
recurrence of pulmonary edema and the presence of 
acute hemorrhagic pleural effusion, the tutors ended 
up opting for euthanasia due to the seriousness of 
the clinical picture and financial unavailability. The 
definitive diagnosis was made through necropsy findings 
and histopathological examination of the tumor mass 
(Figures 2 and 3), confirming extracardiac HSA in the 
base of the left atrium with extension and involvement 
of the aorta and pulmonary arteries, severe hemorrhagic 
pleural effusion and DVTM (Figure 1).
Figure 3 –  Neoplastic mass in left atrium base, involving aorta and pulmonary 
arteries
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HSA has become the neoplasia commonly found in dogs, 
appearing mainly in the atria, accompanied by metastasis in 
other organs such as spleen, liver, and lung (GIRARD et al., 
1999). In the described patient no metastases were found in 
other organs at the necropsy examination, but the presence 
of neoplasia, extraphysical mass, was confirmed in the left 
atrium base by histopathology, identifying as HSA.
Clinical signs observed during clinical care, 
complementary examinations and established 
therapeutics are compatible and recommended for 
the diagnosis and treatment of dogs with functional 
class D DVMT (ATKINS et al., 2009; FRANCO et al., 
2011) cardiogenic pulmonary edema. The clinical and 
echocardiographic findings described with regard to 
the left atrial base neoplasia corroborating with the 
findings reported by Brown et al. (1985) and Ferreira et 
al. (2011). The ventricular arrhythmia observed during 
electrocardiography performed at the time of clinical 
care was described by Warman et al. (2006) as one of 
the findings in patients with SAH. However, myocardial 
hypoxia and cardiac output reduction are observed in 
patients with class D MVDM, in which they justify the 
occurrence of premature ventricular complexes. With 
clinical stabilization, the absence of arrhythmias was 
noted, as in the present case report (GOMES, 2016).
The hematological findings of dogs with SAH are non-
specific, but normochromic normocytic anemia, renal 
azotemia, hyperphosphatemia, and increased liver enzymes 
are described in dogs with SAH and DVMT (WEISSE et 
al., 2005). Anemia is caused by a shift of blood from the 
circulation to the major neoplastic nodules (FERREIRA 
et al., 2011). Renal azotemia and hyperphosphataemia 
are commonly described in dogs with DVTD due to 
impairment of renal perfusion (MARTINELLI et al., 2016). 
However, the increase in liver enzymes is usually due to 
the presence of metastasis (FREIRE, 2009).
Clinical therapy instituted in the maintenance of 
the CHF (REYNOLDS et al., 2012), together with the 
combination of prednisolone aimed at the reduction 
of the neoplastic inflammatory process and cough 
suppression (RUTHERFORD et al., 2016). Ranitidine 
hydrochloride is a histamine H2 receptor antagonist 
and aluminum hydroxide has a phosphorus chelating 
action in an attempt to reduce serum phosphorus 
levels (BECKER, 2011). After 128 days, remission of 
pulmonary edema and hemorrhagic pleural effusion 
occurred. Due to the severity of the clinical situation and 
the financial unavailability of the tutors, they chose to 
perform euthanasia (CFMV, 2012). The justification for 
the worsening of the clinical picture was confirmed in 
the necropsy examination, confirming the extracardiac 
HSA on the basis of the left atrium and base of the aortic 
and pulmonary arteries, suggesting the occurrence of 
compression of the atrium and the great arteries, leading 
to worsening of the CHF. In addition to the rupture 
of tumor vesicles causing acute pleural hemorrhagic 
effusion, facts described by Ferreira et al. (2011) attested 
that patients with HSA due to hypovolemic shock due 
to acute hemorrhage due to rupture of tumor vesicles 
located in peritoneal and/or pericardial cavities.
According to Brown et al. (1985), the definitive 
diagnosis of SAH is given by means of histopathological 
examination, as performed in the present report, with 
its predisposition to occur at the base of the right atrium 
(PALACIO et al., 2006). However, the present study 
describes its presentation at the base of the left atrium 
with involvement of the aorta and pulmonary arteries, 
according to the findings of the necropsy performed.
The description and interpretation of the clinical 
findings and the complementary tests performed 
confirmed the occurrence of left atrial hemangiosarcoma 
in a dog with DVT.
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